0001214659-20-000573.txt : 20200124 0001214659-20-000573.hdr.sgml : 20200124 20200124163017 ACCESSION NUMBER: 0001214659-20-000573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200122 FILED AS OF DATE: 20200124 DATE AS OF CHANGE: 20200124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARLIANT RONALD CENTRAL INDEX KEY: 0001288093 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 20545861 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-47551.xml PRIMARY DOCUMENT X0306 4 2020-01-22 0001293310 HUMANIGEN, INC HGEN 0001288093 BARLIANT RONALD C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 true false false false Stock Option (Right to Buy) 0.38 2020-01-22 4 A false 50000 0.38 A 2020-01-22 2030-01-21 Common Stock 50000 50000 D The stock option was granted in lieu of the $13,500 cash compensation payable to Mr. Barliant in respect of his services as a director during the fourth quarter of 2019. /s/ Cameron Durrant, Attorney-in-Fact 2020-01-24